IL2 and neoplasm: Tumor-secreted GM-CSF is involved in recruiting a population of MDSCs, which have been shown to inhibit IL-2 production from anti-CD3-activated intratumoral T cells and interfere with CD8+ T cell-mediated immunity at the tumor site [23,34,35].